Organophosphorus poisoning can occur when one is exposed to organophosphates for too long or at high levels. Organophosphates are a common type of insecticide. However, high levels of organophosphates can be harmful to humans and other animals.
Organophosphates are useful as pharmaceuticals, pesticides, and as nerve agents. Due to the extensive usage of these chemicals in agriculture, the majority of organophosphate toxicity cases presently involve farmers and other individuals who function in this field.
Organophosphate molecules can penetrate the body through the skin, by inhalation, or through the digestive system
The molecule permeates red blood cells where it binds to an acetylcholinesterase molecule, making the enzyme inactive
This causes synapses and neuromuscular junctions to accumulate an excess of acetylcholine
Myoclonic jerks and fasciculations can occur as a result of the overstimulation of nicotinic receptors at neuromuscular junctions
The depolarizing blockage ultimately results in flaccid paralysis
The adrenal glands have nicotinic receptors, which can lead to hypertension, perspiration, tachycardia, and leukocytosis with a left shift
The effects of organophosphate poisoning on muscarinic receptors result in additional symptoms
G-protein-coupled receptors are responsible for these effects, which are typically slower than those of nicotinic receptors
Organophosphate toxicity has parasympathetic effects on several systems, including the heart, exocrine glands, and smooth muscles
Symptoms range from mild to moderate depending on the exposure to organophosphates, they include:
Mild organophosphate exposure results in:
Moderate organophosphate exposure results in:
Organophosphate poisoning can lead to several significant consequences. These are some examples:
1.
UK government can save lives and smash inequalities by changing prostate cancer guidelines, say experts
2.
Chronic pain and poor sleep are troublesome bed partners.
3.
Saturated Fat Tied to Worse Survival After Prostate Cancer
4.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
5.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
1.
Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer
2.
Adjuvant Atezolizumab in TNBC: What Recent Trials Reveal About Its Role
3.
Exposure Modeling for Bispecific Antibodies: Scientific Foundations and Clinical Implications
4.
Risk Assessment of Treatment-Related Liver Injury in Cancer Care
5.
Advancements in Cancer Treatment and Survival Outcomes for Acute Myeloid Leukemia
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part III
3.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation